Literature DB >> 28664345

Hypoxic dose, intensity distribution, and fatigue monitoring are paramount for "live high-train low".

Jacob Bejder1, Nikolai Baastrup Nordsborg2.   

Abstract

Entities:  

Keywords:  Altitude exposure; Endurance; Performance

Mesh：

Year:  2017        PMID： 28664345     DOI： 10.1007/s00421-017-3665-2

Source DB:  PubMed          Journal:  Eur J Appl Physiol        ISSN： 1439-6319            Impact factor:   3.078


× No keyword cloud information.
  5 in total

1.  Living high-training low: tolerance and acclimatization in elite endurance athletes.

Authors:  Julien V Brugniaux; Laurent Schmitt; Paul Robach; Hervé Jeanvoine; Hugues Zimmermann; Gérard Nicolet; Alain Duvallet; Jean-Pierre Fouillot; Jean-Paul Richalet
Journal:  Eur J Appl Physiol       Date:  2005-10-26       Impact factor: 3.078

2.  "Live high-train low" using normobaric hypoxia: a double-blinded, placebo-controlled study.

Authors:  Christoph Siebenmann; Paul Robach; Robert A Jacobs; Peter Rasmussen; Nikolai Nordsborg; Victor Diaz; Andreas Christ; Niels Vidiendal Olsen; Marco Maggiorini; Carsten Lundby
Journal:  J Appl Physiol (1985)       Date:  2011-10-27

3.  Defining the "dose" of altitude training: how high to live for optimal sea level performance enhancement.

Authors:  Robert F Chapman; Trine Karlsen; Geir K Resaland; R-L Ge; Matthew P Harber; Sarah Witkowski; James Stray-Gundersen; Benjamin D Levine
Journal:  J Appl Physiol (1985)       Date:  2013-10-24

4.  Similar Hemoglobin Mass Response in Hypobaric and Normobaric Hypoxia in Athletes.

Authors:  Anna Hauser; Laurent Schmitt; Severin Troesch; Jonas J Saugy; Roberto Cejuela-Anta; Raphael Faiss; Neil Robinson; Jon P Wehrlin; Grégoire P Millet
Journal:  Med Sci Sports Exerc       Date:  2016-04       Impact factor: 5.411

5.  The road to gold: training and peaking characteristics in the year prior to a gold medal endurance performance.

Authors:  Espen Tønnessen; Øystein Sylta; Thomas A Haugen; Erlend Hem; Ida S Svendsen; Stephen Seiler
Journal:  PLoS One       Date:  2014-07-14       Impact factor: 3.240
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.